Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.46 -3.59% -0.13
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IRWD stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 570.7M
Enterprise value 972.6M
Trailing PE 23.333332
Forward PE 2.4027405
PEG Ratio -0.15555554666667
Enterprise to EBITDA 8.062
Enterprise to revenue 3.284
Price to book MRQ -2.1651235761037
Price to sales TTM 1.9270713

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-12-31
Revenue (TTM) 296.2M
EBITDA 124.9M
Diluted EPS TTM 0.15
Total Cash (MRQ) 215.5M
Current ratio (MRQ) 1.132
Operating Cash Flow (TTM) 127.0M

IRWD trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent IRWD News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.